Literature DB >> 20573052

Case for and against specificity of depression in Alzheimer's disease.

Christian Even1, Daniel Weintraub.   

Abstract

AIMS: The aims of this study were to assess the epidemiological, phenomenological, and pathophysiological evidence that suggests the specificity of depression associated with Alzheimer's disease (AD).
METHODS: We reviewed the English-language literature.
RESULTS: Depression occurs significantly more often in patients with AD than in the general elderly population. While development of depression in response to the disability and emotional stress of AD may be a contributory factor in some patients, several studies showed that depression was not, or was only seldom, related to self-awareness of AD and these studies could not explain the high prevalence figures. To overcome the overlapping phenomenology of the two diseases, specific diagnostic criteria have been developed for depression in this context. Mixed findings have come from neuropathological and neuroimaging studies, with some evidence linking the underlying neural substrate of AD and depression, suggesting an overlapping cause of primary depression and depression comorbid with AD. Few randomized controlled trials for depression associated with AD have been conducted, with rather poor results for the use of antidepressants.
CONCLUSIONS: Currently, depression associated with AD is not considered a separate disorder by regulatory authorities and is unlikely to be considered as such in the near future. Several obstacles remain to support such a specific position, including the heterogenous nature of depression in general and within AD itself, the lack of a distinct set of symptoms, and limited treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573052     DOI: 10.1111/j.1440-1819.2010.02108.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

1.  Measuring symptoms of depression: comparing the Cornell Scale for Depression in Dementia and the Patient Health Questionnaire-9-Observation Version.

Authors:  Lorraine J Phillips
Journal:  Res Gerontol Nurs       Date:  2011-12-14       Impact factor: 1.571

2.  Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics.

Authors:  Lawrence S Honig; Clara D Boyd
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09

Review 3.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

4.  Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice.

Authors:  Sagar Patel; J Alex Grizzell; Rosalee Holmes; Ross Zeitlin; Rosalynn Solomon; Thomas L Sutton; Adeeb Rohani; Laura C Charry; Alexandre Iarkov; Takashi Mori; Valentina Echeverria Moran
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.